Search - tctmd.com

Displaying 1 - 20 of 40

Sort: Relevancy | Date

News Daily News

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Michael O'Riordan

December 06, 2018

News Features

Country Roads: Vulnerable West Virginia Heart Patients Targeted in Outreach Program

Michael O'Riordan

October 29, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2018

Shelley Wood

October 02, 2018

News Conference News TCT 2018

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

L.A. McKeown

September 27, 2018

Top Stories in Cardiology: September 2018

Podcast Heart Sounds

Case #10: An Arch Complication After Aortic Coarctation Stenting

Presenter: Lee N. Benson, Eric Horlick, Zahid Amin, Makram R. Ebeid, Ioannis Iakovou, Michael J. Lim, Mark Osten, Harsimran Sachdeva Singh, Nathan W Taggart

September 22, 2018

News Conference News TCT 2018

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Shelley Wood

September 17, 2018

News Daily News

Early Discharge Safe in Patients Undergoing TAVR, Meta-analysis Shows

Michael O'Riordan

September 12, 2018

News Conference News ESC 2018

Updated ESC Guidelines Introduce Concept of a Pregnancy Heart Team for Women With CVD

Todd Neale

August 31, 2018

News Conference News ESC 2018

Weight-Loss Drug Lorcaserin Clears Cardiovascular Safety Hurdle: CAMELLIA-TIMI 61

Michael O'Riordan

August 26, 2018

News Daily News

Women Likely Not Good Targets for AAA Screening, Study Suggests

Lucy Hicks

August 13, 2018

News Daily News

Best-Yet Study of Footballers Raises New Questions Over Preparticipation Cardiac Tests for Athletes

Michael O'Riordan

August 09, 2018

News Daily News

Late Conduction Defects After TAVR: Finding ‘Sweet Spot’ for Early Discharge

Michael O'Riordan

August 08, 2018

News Daily News

‘We Have to Go to Them’: New Global Initiative for Treating Rheumatic Heart Disease

Michael O'Riordan

August 06, 2018

News Daily News

TCTMD’s Top 10 Most Popular Stories for July 2018

Shelley Wood

August 01, 2018

News Daily News

Less Stroke With PCI at 5 Years, but CABG Risks Front-loaded in First 30 Days

Michael O'Riordan

July 19, 2018

News Daily News

Lp(a) Might Not Be Good at Predicting Incident CVD in Low-Risk Women

Yael L. Maxwell

July 09, 2018

News Conference News The Structural Heart Disease Summit 2018

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Michael O'Riordan

June 22, 2018

News Conference News The Structural Heart Disease Summit 2018

Nearly 25% of AVR Patients Experience Anxiety or Depression in First Year

Michael O'Riordan

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Pharmacotherapy Considerations Trials and Practical Clinical Recommendations

Presenter: George D. Dangas

June 21, 2018

Advertisement

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Country Roads: Vulnerable West Virginia Heart Patients Targeted in Outreach Program

TCTMD’s Top 10 Most Popular Stories for September 2018

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

Top Stories in Cardiology: September 2018

Case #10: An Arch Complication After Aortic Coarctation Stenting

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Early Discharge Safe in Patients Undergoing TAVR, Meta-analysis Shows

Updated ESC Guidelines Introduce Concept of a Pregnancy Heart Team for Women With CVD

Weight-Loss Drug Lorcaserin Clears Cardiovascular Safety Hurdle: CAMELLIA-TIMI 61

Women Likely Not Good Targets for AAA Screening, Study Suggests

Best-Yet Study of Footballers Raises New Questions Over Preparticipation Cardiac Tests for Athletes

Late Conduction Defects After TAVR: Finding ‘Sweet Spot’ for Early Discharge

‘We Have to Go to Them’: New Global Initiative for Treating Rheumatic Heart Disease

TCTMD’s Top 10 Most Popular Stories for July 2018

Less Stroke With PCI at 5 Years, but CABG Risks Front-loaded in First 30 Days

Lp(a) Might Not Be Good at Predicting Incident CVD in Low-Risk Women

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Nearly 25% of AVR Patients Experience Anxiety or Depression in First Year

Pharmacotherapy Considerations Trials and Practical Clinical Recommendations

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content